0
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.19.47.197. Please contact the publisher to request reinstatement.
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Clinical Challenges in Otolaryngology |

Use of Cidofovir for Treatment of Recurrent Respiratory Papillomatosis

Craig Derkay, MD
Arch Otolaryngol Head Neck Surg. 2009;135(2):198-201. doi:10.1001/archoto.2008.539.
Text Size: A A A
Published online

Extract

Hypothesis: Intralesional cidofovir should be routinely considered in the treatment of recurrent respiratory papillomatosis (RRP).

REFERENCES
Derkay  CS Task Force on Recurrent Respiratory Papillomas. Arch Otolaryngol Head Neck Surg 1995;121 (12) 1386- 1391
PubMed Link to Article[[XSLOpenURL/10.1001/archotol.1995.01890120044008]]
Derkay  CSDarrow  DH Recurrent respiratory papillomatosis (RRP) Ann Otol Rhinol Laryngol 2006;115 (1) 1- 11
PubMed
Johnson  JAGangemi  JD Selective inhibition of human papillomavirus-induced cell proliferation by (s)-1-[3-hydroxy-2-(phosphonylmethoxy) propylcytosine. Antimicrob Agents Chemother 1999;43 (5) 1198- 1205
PubMed
See  RFRao  NA Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy. Ophthalmol Clin North Am 2002;15 (4) 529- 536
PubMed Link to Article[[XSLOpenURL/10.1016/S0896-1549(02)00048-2]]
Gilead Sciences Inc, Vistide. Thomson  HealthcarePhysicians' Desk Reference. Montvale, NJ Thomson Healthcare2003;1428- 1432
Pransky  SMAlbright  JTMagit  AE Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope 2003;113 (9) 1583- 1587
PubMed Link to Article[[XSLOpenURL/10.1097/00005537-200309000-00032]]
Chadha  NKJames  AL Antiviral agents for the treatment of recurrent respiratory papillomatosis: a systematic review of the English-language literature. Otolaryngol Head Neck Surg 2007;136 (6) 863- 869
PubMed Link to Article[[XSLOpenURL/10.1016/j.otohns.2006.09.007]]
Tanna  NSidel  DJoshi  ASBielamowicz  SA Adult intralesional cidofovir therapy for laryngeal papilloma. Arch Otolaryngol Head Neck Surg 2008;134 (5) 497- 500
PubMed Link to Article[[XSLOpenURL/10.1001/archotol.134.5.497]]
Naiman  ANAyari  SNicollas  RLandry  GColombeau  BFroelich  P Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis. Ann Otol Rhinol Laryngol 2006;115 (9) 667- 672
PubMed
Shehab  NSweet  BVHogikyan  ND Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature. Pharmacotherapy 2005;25 (7) 977- 989
PubMed Link to Article[[XSLOpenURL/10.1592/phco.2005.25.7.977]]
Schraff  SDerkay  CSBurke  BLawson  L American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 2004;130 (9) 1039- 1042
PubMed Link to Article[[XSLOpenURL/10.1001/archotol.130.9.1039]]
Andrei  GSnoeck  RSchols  DDeClercq  E Induction of apoptosis by cidofovir in human papillomavirus-positive cells. Oncol Res 2000;12 (9-10) 397- 408
PubMed
Snoeck  RWellens  WDesloovere  C  et al.  Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine]. J Med Virol 1998;54 (3) 219- 225
PubMed Link to Article[[XSLOpenURL/10.1002/(ISSN)1096-9071]]
Pransky  SMBrewster  DFMagit  AEKearns  DB Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2000;126 (10) 1239- 1243
PubMed Link to Article[[XSLOpenURL/10.1001/archotol.126.10.1239]]
Chhetri  DKShapiro  NL A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir. Arch Otolaryngol Head Neck Surg 2003;129 (10) 1081- 1085
PubMed Link to Article[[XSLOpenURL/10.1001/archotol.129.10.1081]]
Bielamowicz  SVillagomez  VStager  SVWilson  WR Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort. Laryngoscope 2002;112 (4) 696- 699
PubMed Link to Article[[XSLOpenURL/10.1097/00005537-200204000-00019]]
Lee  ASRosen  CA Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis J Voice 2004;18 (4) 551- 556
PubMed Link to Article[[XSLOpenURL/10.1016/j.jvoice.2003.07.007]]
Mandell  DLArjimand  EMKay  DJCasselbrant  MLRosen  CA Intralesional cidofovir for pediatric recurrent respiratory papillomatosis Arch Otolaryngol Head Neck Surg 2004;130 (11) 1319- 1323
PubMed Link to Article[[XSLOpenURL/10.1001/archotol.130.11.1319]]
Co  JWoo  P Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2004;113 (11) 859- 862
PubMed
Akst  LMLee  WDiscolo  CKnott  DYounes  AKoltai  PJ Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 2003;129 (8) 841- 846
PubMed Link to Article[[XSLOpenURL/10.1001/archotol.129.8.841]]
Peyton Shirley  WWiatrak  B Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children? Int J Pediatr Otorhinolaryngol 2004;68 (4) 413- 418
PubMed Link to Article[[XSLOpenURL/10.1016/j.ijporl.2003.11.007]]
El Hakim  HWaddell  ANCrysdale  WS Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir. J Otolaryngol 2002;31 (6) 333- 335
PubMed Link to Article[[XSLOpenURL/10.2310/7070.2002.34526]]
Milczuk  HA Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long term results in 4 children. Otolaryngol Head Neck Surg 2003;128 (6) 788- 794
PubMed Link to Article[[XSLOpenURL/10.1016/S0194-5998(03)00259-6]]
McMurray  JSFord  C Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study. Ann Otol Rhinol Laryngol 2008;117 (7) 477- 483
PubMed
Naiman  ANAbedipour  DAyari  S  et al.  Natural history of adult-onset laryngeal papillomatosis following multiple cidofovir injections. Ann Otol Rhinol Laryngol 2006;115 (3) 175- 181
PubMed
Wemer  RDLee  JHHoffman  HTRobinson  RASmith  RJ Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2005;114 (11) 836- 839
PubMed
Lindsay  FPransky  SBrewster  D  et al.  Histologic review of cidofovir-treated recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2008;117 (2) 113- 117
PubMed
Boston  MDerkay  CS Recurrent respiratory papillomatosis. Clin Pulmonary Med 2003;1010- 16
Link to Article[[XSLOpenURL/10.1097/00045413-200301000-00003]]
Inglis  AF  Jr Cidofovir and the black box warning Ann Otol Rhinol Laryngol 2005;114 (11) 834- 835
PubMed
Naiman  ANRoger  GGagnieu  MC  et al.  Cidofovir plasma assays after local injection in respiratory papillomatosis. Laryngoscope 2004;114 (7) 1151- 1156
PubMed Link to Article[[XSLOpenURL/10.1097/00005537-200407000-00004]]
Derkay  CMulti-Disciplinary Task Force on Recurrent Respiratory Papillomas, Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks. Int J Pediatr Otorhinolaryngol 2005;69 (11) 1465- 1467
PubMed Link to Article[[XSLOpenURL/10.1016/j.ijporl.2005.08.007]]
Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption

Craig Derkay, MD

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

110 Views
15 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();